Connect your AI

Pagaya Technologies PGY Increase Decrease In Operating Right Of Use Asset

Increase Decrease In Operating Right Of Use Asset at other companies

Ondas, Inc. ONDS

$68K—

Theravance BiopharmaTBPH

-$314K-848%

Pagaya TechnologiesPGY

-$1.61M-7.2%

Intellia TherapeuticsNTLA

-$8.41M-16.5%

WorkivaWK

-$1.26M+5.2%

VenHub Global, Inc. VHUB

-$56.18K-186%

Other financials

Income statement

Revenue$317.9M+9.6%

Gross profit$140.4M+14.2%

Operating income$80.0M+67.8%

Net income$24.7M+213%

EPS (diluted)$0.28+180%

Balance sheet

Cash & equivalents$380.0M+65.5%

Total debt$507.6M+43.8%

Total equity$529.3M+57.8%

Total assets$1.6B+29.0%

Cash flow

Operating cash flow$43.2M+25.4%

CapEx$3.2M-15.9%

Free cash flow$40.0M+30.5%

Valuation

Market cap$1.26B-9.9%

Enterprise value$1.39B-8.8%

P/E12.8×—

P/S1×-0.4×

Profitability

Gross margin42.9%+0.4pp

Operating margin22.3%+12.4pp

Net margin7.4%+4.0pp

FCF margin17.6%—

Returns & leverage

Return on equity22.7%+12.8pp

Debt / equity1×-0.1×

Current ratio1.4×-0.1×

Where this comes from

Reported directly by Pagaya Technologies in its filing.

Tagged under the XBRL concept pgy:IncreaseDecreaseInOperatingRightOfUseAsset.

The official record: Pagaya Technologies’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pagaya Technologies's increase decrease in operating right of use asset.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Pagaya Technologies's increase decrease in operating right of use asset?: Pagaya Technologies (PGY) reported increase decrease in operating right of use asset of -$1.61M in Q1 2026.